Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

March 31, 2007

Conditions

Carcinoma, Renal Cell

Interventions

DRUG

Recombinant Human Lactoferrin

Trial Locations (6)

Cleveland Clinic Taussig Cancer Center, Cleveland

The University of Chicago Medical Center, Chicago

M.D. Anderson Cancer Center, Houston

VA Medical Center/Baylor College of Medicine, Houston

University of California, Los Angeles

Stanford University School of Medicine, Stanford